Peripheral polyneuropathy and monoclonal gammopathy of undetermined significance.
AUTOR(ES)
Krol-v Straaten, M J
RESUMO
The prevalence of peripheral polyneuropathy in patients with monoclonal gammopathy is known to be higher than in the general population. A prevalence as high as that in the series of Osby et al, who found clinical and/or electrophysiological evidence compatible with peripheral polyneuropathy in 15 of 21 patients has not been reported before. These results could not be confirmed in a study in which 19 patients with benign monoclonal gammopathy were investigated. In contrast there were only two patients with questionable evidence of peripheral neuropathy: one had lower limb symptoms and signs only, the other had evidence of a subclinical polyneuropathy with some abnormalities of nerve conduction.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1028416Documentos Relacionados
- CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
- Monoclonal gammopathy of undetermined significance: new insights
- Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study